Impact of Using the Airseal System with Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: a Prospective, Comparative, Randomized Clinical Study.

Launched by BRAZILIAN INSTITUTE OF ROBOTIC SURGERY · Jan 15, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the use of a special system called the AirSeal during robotic surgery for prostate cancer. The goal is to see if using AirSeal, which helps create a lower pressure inside the abdomen, can lead to better outcomes compared to traditional methods. Researchers want to learn if this system can help reduce surgery time, shorten hospital stays, and lower the risk of complications for patients.

To participate in this study, you need to be a male patient aged between 18 and 65 with prostate cancer who is scheduled for robotic prostate surgery. Unfortunately, those with certain health issues, like severe kidney problems or allergies to certain pain medications, cannot take part. If you join the study, you will be closely monitored to see how well the AirSeal system works and whether it improves your recovery experience. This research aims to gather more information to help future patients benefit from advanced surgical techniques.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Patients with prostate cancer who will undergo robotic prostatectomy;
• Exclusion Criteria:
• • Patients over 65 and under 18 years of age;
• • Patients allergic to NSAIDs and/or Morphine and/or Tramadol;
• • Patients with chronic renal failure;
• • Patients with recurrence, metastasis and other existing neoplasms.